CNY 5.93
(10.02%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 2.93 Billion | 2.52 Billion | 4.29 Billion | 3.44 Billion | 3.79 Billion | 4.2 Billion |
Cost of Revenue | 1.9 Billion | 1.78 Billion | 2.79 Billion | 2.19 Billion | 2.49 Billion | 2.64 Billion |
Gross Profit | 1.02 Billion | 740.51 Million | 1.5 Billion | 1.25 Billion | 1.3 Billion | 1.56 Billion |
Operating Expenses | 1.27 Billion | 1.47 Billion | 1.31 Billion | 1.09 Billion | 1.33 Billion | 1.19 Billion |
Selling, General and Administrative Expenses | 855.88 Million | 1.05 Billion | 913.07 Million | 757.45 Million | 936.66 Million | 838.79 Million |
Research and Development Expenses | 153.49 Million | 166.57 Million | 169.16 Million | 147.71 Million | 163.74 Million | 130.03 Million |
Other Expenses | 61.52 Million | 248.61 Million | 234.84 Million | 192.52 Million | 235.4 Million | 15.6 Million |
Cost and Expenses | 3.17 Billion | 3.25 Billion | 4.1 Billion | 3.29 Billion | 3.82 Billion | 3.84 Billion |
Operating Income | -242.85 Million | -734.14 Million | 197.23 Million | 185.68 Million | 78.64 Million | 379.95 Million |
Interest Expense | 41.15 Million | 29.67 Million | 20.88 Million | 2.94 Million | 4.01 Million | 6.45 Million |
Income Tax Expense | -56.08 Million | -121.72 Million | 1.1 Million | 41.53 Million | 29.74 Million | 87.68 Million |
Earnings before Tax | -236.7 Million | -898.19 Million | 120.17 Million | 258.73 Million | -166.11 Million | 395.56 Million |
Net Income | -208.46 Million | -776.46 Million | 119.06 Million | 180.32 Million | -195.86 Million | 252.64 Million |
Earnings Per Share Basic | -0.50 | -1.85 | 0.28 | 0.43 | -0.47 | 0.61 |
Earnings Per Share Diluted | -0.50 | -1.85 | 0.28 | 0.43 | -0.47 | 0.60 |
Weighted Average Shares Outstanding | 416.93 Million | 419.53 Million | 419.53 Million | 419.53 Million | 419.53 Million | 417.07 Million |
Weighted Average Shares Outstanding (Diluted) | 416.93 Million | 419.53 Million | 419.53 Million | 419.53 Million | 419.53 Million | 421.07 Million |
Gross Margin | 0.35 | 0.29 | 0.35 | 0.36 | 0.34 | 0.37 |
EBIT Margin | -0.01 | -0.21 | 0.09 | 0.07 | 0.03 | 0.11 |
Profit Margin | -0.07 | -0.31 | 0.03 | 0.05 | -0.05 | 0.06 |
EBITDA | -30.2 Million | -602.05 Million | 351.21 Million | 335.8 Million | -69.93 Million | 473.23 Million |
Earnings Before Tax Margin | -0.08 | -0.29 | 0.05 | 0.05 | 0.02 | 0.09 |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Revenue | 251.24 Million | 442.06 Million | 439.58 Million | 835.2 Million | 2.93 Billion | 762.97 Million |
Cost of Revenue | 149.7 Million | 328.16 Million | 299.43 Million | 496.91 Million | 1.9 Billion | 507.98 Million |
Gross Profit | 101.53 Million | 113.89 Million | 140.15 Million | 338.28 Million | 1.02 Billion | 254.98 Million |
Operating Expenses | 174.42 Million | 280.11 Million | 274.99 Million | 299.51 Million | 1.19 Billion | 297.67 Million |
Selling, General and Administrative Expenses | 162.13 Million | 149.62 Million | 237.71 Million | 86.09 Million | - | 346.27 Million |
Research and Development Expenses | 7.97 Million | 10.88 Million | 34.26 Million | 36.82 Million | - | 45.13 Million |
Other Expenses | -12.28 Million | -210.65 Million | 3.56 Million | -5.58 Million | 5.86 Million | 3.13 Million |
Cost and Expenses | 324.12 Million | 608.27 Million | 574.42 Million | 796.43 Million | 3.1 Billion | 805.66 Million |
Operating Income | -72.88 Million | -184.92 Million | -136.26 Million | -4.3 Million | -242.85 Million | -46.32 Million |
Interest Expense | 5.07 Million | 5.88 Million | 6.89 Million | 9.46 Million | 36.45 Million | 9.03 Million |
Income Tax Expense | -4.95 Million | 26.4 Million | -17.85 Million | -12.9 Million | -56.08 Million | -5.17 Million |
Earnings before Tax | -51.57 Million | -395.57 Million | -132.69 Million | -9.6 Million | -236.7 Million | -43.18 Million |
Net Income | -41.18 Million | -423.96 Million | -116 Million | -12.07 Million | -208.46 Million | -46.59 Million |
Earnings Per Share Basic | -0.10 | -1.01 | -0.28 | -0.03 | - | -0.11 |
Earnings Per Share Diluted | -0.10 | -1.01 | -0.28 | -0.03 | - | -0.11 |
Weighted Average Shares Outstanding | 419.53 Million | 419.53 Million | 414.3 Million | 414.18 Million | 416.93 Million | 419.53 Million |
Weighted Average Shares Outstanding (Diluted) | 419.53 Million | 419.53 Million | 414.3 Million | 414.18 Million | 416.93 Million | 419.53 Million |
Gross Margin | 0.40 | 0.26 | 0.32 | 0.41 | 0.35 | 0.33 |
EBIT Margin | -0.19 | -0.85 | -0.30 | 0.04 | - | -0.05 |
Profit Margin | -0.16 | -0.96 | -0.26 | -0.01 | -0.07 | -0.06 |
EBITDA | -46.5 Million | -376.41 Million | -130.63 Million | 33.15 Million | - | -39.12 Million |
Earnings Before Tax Margin | -0.29 | -0.42 | -0.31 | -0.01 | -0.08 | -0.06 |
LPE
3179
LRK
BPLPHARMA
3091
0LIU